ABSTRACT
A 60-year-old male patient presented to our clinic with metastatic [bone and bone marrow] prostate cancer. Radiotherapy [RT] with a total of 30 Gy was planned in 10 fractions for the painful left shoulder region. On the 6th day of RT, urinary output decreased suddenly and dyspnea developed. Laboratory findings suggested tumor lysis syndrome [TLS]. The patient, who showed improvement in overall status and had no requirement for hemodialysis up to this time, developed sudden impairment in overall status, dyspnea, and hypotension on the 11th day of follow-up. Thirty minutes after the development of these symptoms, the patient had a cardiopulmonary arrest and died. At the time of writing this was the fourth case of TLS during RT for solid tumors in adults, the first case of TLS during RT for prostate cancer and the fifth among total cases of prostate cancer in published reports
Subject(s)
Humans , Male , Radiotherapy/adverse effects , Prostatic Neoplasms/radiotherapy , Neoplasm Metastasis , Bone Neoplasms , Bone Marrow Neoplasms , VisceraABSTRACT
Extramedullary hematopoiesis is a common finding in idiopathic myelofibrosis and is generally found in the liver, spleen and lymph nodes, but meningeal extramedullary hematopoiesis is very rare. Some diseases may be causes of intracranial masses and diagnosis is difficult. We present a case diagnosed as intracranial and meningeal extramedullary hematopoiesis with idiopathic myelofibrosis inducing serious headache
Subject(s)
Humans , Male , Primary Myelofibrosis/diagnosis , Primary Myelofibrosis/etiology , Primary Myelofibrosis/etiology , Brain/pathology , Tomography, X-Ray ComputedABSTRACT
Aase-Smith syndrome type II is rare in childhood and there are few reported cases. Here, we report an 8-month-old boy with congenital red cell aplasia and triphalangeal thumbs. In addition to thumb anomalies, he presented with growth failure, hypertelorism and novel osseous radiologic abnormalities, large fontanelles and micrognathia as extraordinary. Some clinical symptoms had complete clinical remission with deflazacort treatment